Robust Antigen-Specific T Cell Activation within Injectable 3D Synthetic Nanovaccine Depots

[Image: see text] Synthetic cancer vaccines may boost anticancer immune responses by co-delivering tumor antigens and adjuvants to dendritic cells (DCs). The accessibility of cancer vaccines to DCs and thereby the delivery efficiency of antigenic material greatly depends on the vaccine platform that...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiden, Jorieke, Schluck, Marjolein, Ioannidis, Melina, van Dinther, Eric A. W., Rezaeeyazdi, Mahboobeh, Omar, Fawad, Steuten, Juulke, Voerman, Dion, Tel, Jurjen, Diken, Mustafa, Bencherif, Sidi A., Figdor, Carl G., Verdoes, Martijn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672349/
https://www.ncbi.nlm.nih.gov/pubmed/34734689
http://dx.doi.org/10.1021/acsbiomaterials.0c01648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672349/
https://www.ncbi.nlm.nih.gov/pubmed/34734689
http://dx.doi.org/10.1021/acsbiomaterials.0c01648

Ejemplares similares